Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-21-131784
Filing Date
2021-10-29
Accepted
2021-10-29 16:08:24
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2130536-1_424b5.htm 424B5 303152
2 GRAPHIC lg_casipharmaceuticals-4clr.jpg GRAPHIC 31478
  Complete submission text file 0001104659-21-131784.txt   347774
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-250801 | Film No.: 211363324
SIC: 2836 Biological Products, (No Diagnostic Substances)